In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews for November 2012.

Pharmaceutical Technology
Volume 36, Issue 11, pp. 24

Software enables efficient electronic batch recording



Rockwell Software PharmaSuite contains a comprehensive set of functions that address the most common applications, such as dispensing, quality, and electronic batch recording. The software tracks material, equipment, and personnel involved in the manufacturing process and maintains a complete electronic batch record. Rockwell Software PharmaSuite is based on S88 and S95 standards which allows for better integration with other enterprise systems involved in manufacturing operations. Its object-oriented design enables a user-friendly functionality to build and modify applications, and systematically deploy them across multiple sites.

Rockwell Automation
http://www.rockwellautomation.com/
Software is available worldwide

Web-based system provides real-time management of processes



Data acquisition, system integration, and information deployment is enabled via the latest version of Yokogawa's FAST/TOOLS R9.05 SCADA software. The visualization software can be used to monitor main production facilities, as well as for the real-time capture of key operational, maintenance, and business information. In the latest version, the variety and number of alarms have increased with the introduction of more intelligent functions in process installations and the integration of data from other systems into the SCADA environment. Functionality is also provided for mobile devices, including tablets and smart phones.

Yokogawa
http://www.yokogawa.com/
Software is available worldwide


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here